Daniel Moorhead Purchases 4,340 Shares of Beyond Air (NASDAQ:XAIR) Stock

Beyond Air, Inc. (NASDAQ:XAIR) CFO Daniel Moorhead acquired 4,340 shares of the stock in a transaction on Wednesday, July 29th. The stock was bought at an average price of $5.76 per share, for a total transaction of $24,998.40. Following the transaction, the chief financial officer owned 4,340 shares in the company, valued at approximately $24,998.40. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Beyond Air Stock Performance

Shares of NASDAQ:XAIR traded down $0.14 during trading on Friday, hitting $5.28. 27,954 shares of the stock traded hands, compared to its average volume of 168,749. The company has a quick ratio of 3.59, a current ratio of 3.80 and a debt-to-equity ratio of 3.48. The company has a market cap of $3.81 million, a price-to-earnings ratio of -0.06 and a beta of 0.22. The company has a fifty day moving average price of $7.75 and a two-hundred day moving average price of $14.27. Beyond Air, Inc. has a 52-week low of $5.02 and a 52-week high of $95.60.

Beyond Air (NASDAQ:XAIR) last posted its earnings results on Friday, June 26th. The company reported ($15.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($11.33) by ($4.07). Beyond Air had a negative net margin of 432.99% and a negative return on equity of 350.00%. The firm had revenue of $1.91 million during the quarter, compared to analyst estimates of $2.30 million.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Beyond Air in a research note on Tuesday, July 21st. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $200.00.

Institutional Trading of Beyond Air

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC lifted its position in shares of Beyond Air by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 838,319 shares of the company’s stock valued at $144,000 after buying an additional 12,598 shares in the last quarter. Virtu Financial LLC purchased a new stake in Beyond Air in the 3rd quarter worth $48,000. Osaic Holdings Inc. increased its holdings in Beyond Air by 26.4% in the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after acquiring an additional 34,000 shares in the last quarter. Finally, Alyeska Investment Group L.P. acquired a new position in Beyond Air during the third quarter worth $1,753,000. 31.50% of the stock is currently owned by hedge funds and other institutional investors.

About Beyond Air

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.